Results 101 to 110 of about 2,161,173 (316)
ABSTRACT Objective Autosomal dominant progranulin (GRN) pathogenic variants are a genetic cause of frontotemporal lobar degeneration. Though clinical trials for GRN‐related therapies are underway, there is an unmet need for biomarkers that can predict symptom onset and track disease progression.
Taru M. Flagan+46 more
wiley +1 more source
Protein Metabolism. Influence of Growth Hormone, Anabolic Steroids, and Nutrition in Health and Disease. An International Symposium, Leyden, 25th-29th June, 1962 [PDF]
openalex +1 more source
Practice Recommendations for Genetic Testing of Ataxias
ABSTRACT Objective Over the past decade, significant advances in genetic testing for ataxia have improved diagnostic accuracy, informed clinical trial eligibility, guided treatment decisions, and enabled cascade testing of at‐risk relatives. While guidance exists for other neurogenetic conditions, there are no standardized guidelines on genetic ...
Sharan R. Srinivasan+7 more
wiley +1 more source
Health Education in a Cambodian Village: International Mail Pouch [PDF]
Mary L. Mills
openalex +1 more source
ABSTRACT Objective Cognitive impairment (CI) affects the quality of life in multiple sclerosis (MS). Identifying influencing factors is key to improving CI monitoring. This systematic review and meta‐analysis examines clinical and sociodemographic variables impacting the cognitive screening Symbol Digit Modalities Test (SDMT) performance across MS ...
Katalin Lugosi+8 more
wiley +1 more source
Kuskaya: A training program for collaboration and innovation in global health
Michelle C Chan,1 Angela M Bayer,1 Joseph R Zunt,2 Magaly M Blas,1 Patricia J Garcia1 1School of Public Health and Administration, Universidad Peruana Cayetano Heredia, Lima, Peru; 2Departments of Neurology and Global Health, University of Washington ...
Chan MC+4 more
doaj
Pre‐Diagnostic Features of Multiple Sclerosis in a Diverse UK Cohort: A Nested Case–Control Study
ABSTRACT Background Many patients with Multiple Sclerosis (MS) experience nonspecific symptoms prior to diagnosis. This period—the 'MS prodrome'—has been described in socio‐economically homogeneous cohorts to date. It remains unclear to what extent events prior to an MS diagnosis differ according to social determinants of health. Methods We conducted a
Pooja Tank+3 more
wiley +1 more source
Development of International Coöperation Among the Health Authorities of the American Republics
Hugh S. Cumming
openalex +1 more source
Longitudinal changes in salivary biomarkers in Parkinson’s disease (PD) from early (T0) to 4‐year follow‐up (T1), quantified by ELISA: oligomeric and total α‐synuclein, total and phosphorylated tau, MAP1LC3B (autophagy), and TNFa (inflammation). Blue arrows indicate direction of change at T1 vs T0 (up = increase; down = decrease).
Maria Ilenia De Bartolo+13 more
wiley +1 more source